{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:00:56Z","timestamp":1789621256016,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Candidemia is the most frequent pediatric fungal infection, but incompletely elucidated in population-based settings. We performed a nationwide cohort study including all pediatric patients with candidemia in Denmark from 2004 to 2014 to determine age, incidence, species distribution, underlying diseases, patient management and outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All candidemia episodes were identified through the active nationwide fungemia surveillance program. Susceptibility testing followed the EUCAST E.Def 7 (European Committee on Antifungal Susceptibility Testing, Edition Definitive) reference method. \u03c7<jats:sup>2<\/jats:sup> test, Fisher exact test and Venn diagrams were used for statistical analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred fifty-three pediatric patients (\u2264 15 years) with 158 candidemia episodes were identified. The overall annual incidence rate was 1.3\/100,000 population, higher for neonates (5.7\/100,000 live births) and low birth weight neonates (103.8\/100,000 live births). From 2004 to 2009 to 2010 to 2014, the proportion of <jats:italic toggle=\"yes\">Candida albicans<\/jats:italic> decreased from 74.4% to 64.7%, whereas fluconazole resistance increased from 7.8% to 17.7%. Virtually all patients had at least 1 underlying disease (98.6%) and multimorbidity was common (43.5%, \u22652 underlying diseases). Underlying diseases differed by age with heart malformations and gastrointestinal disease prevalent in children younger than 3 years. The overall 30-days mortality was 10.2% and highest for neonates (17.1%). Mortality increased from 2004 to 2010 to 2014, driven by an increase among older children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This first nationwide epidemiologic study of pediatric candidemia confirmed a high incidence among neonates and a substantial burden of comorbidities. Moreover, an increasing proportion of fluconazole resistant nonalbicans species was observed. Our findings underline the importance of choosing correct treatment and continuous surveillance of pediatric candidemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002207","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T15:33:02Z","timestamp":1538580782000},"page":"464-469","source":"Crossref","is-referenced-by-count":36,"title":["Pediatric Candidemia Epidemiology and Morbidities"],"prefix":"10.1097","volume":"38","author":[{"given":"Karen Rokkedal","family":"Lausch","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia Hee","family":"Schultz Dungu","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Thude","family":"Callesen","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Schr\u00f8der","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"Rosth\u00f8j","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Aalborg University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Leth","family":"Mortensen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Storgaard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Carl","family":"Sch\u00f8nheyder","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Aalborg University Hospital"},{"name":"Department of Clinical Medicine, University of Aalborg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aalborg University Hospital"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken Cavling","family":"Arendrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital"},{"name":"Unit of Mycology, Statens Serum Institute, Copenhagen"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/INF.0b013e31824da7fe","article-title":"Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.","volume":"31","author":"Dotis","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ajic.2016.03.056","article-title":"Epidemiologic and microbiologic evaluation of nosocomial infections associated with Candida spp in children: a multicenter study from Istanbul, Turkey.","volume":"44","author":"Sutcu","year":"2016","journal-title":"AJIC Am J Infect Control"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jpc.12905","article-title":"Candida species bloodstream infections in hospitalised children: a 10-year experience.","volume":"51","author":"Chan","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/INF.0000000000000039","article-title":"Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome.","volume":"33","author":"Santolaya","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2334-10-312","article-title":"Secular trend in candidemia and the use of fluconazole in Finland, 2004\u20132007.","volume":"10","author":"Poikonen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.","volume":"20","author":"Puig-Asensio","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidaemia surveillance: results from a Norwegian national study.","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3201\/eid1210.060389","article-title":"Active surveillance for candidemia, Australia.","volume":"12","author":"Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011.","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011.","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1093\/jpids\/piy009","article-title":"Neonatal and pediatric candidemia: results from population-based active laboratory surveillance in four US locations, 2009\u20132015.","volume":"7","author":"Benedict","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R12-20230912","article-title":"Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern.","volume":"56:e01564\u201317","author":"Astvad","year":"2018","journal-title":"J Clin Microbiol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009).","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12535","article-title":"Differences in epidemiology of candidaemia in the Nordic countries \u2013 what is to blame?","volume":"60","author":"Hesstvedt","year":"2017","journal-title":"Mycoses"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41598-017-01123-6","article-title":"Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.","volume":"7","author":"Tsai","year":"2017","journal-title":"Sci Rep"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10408410903213393","article-title":"Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.","volume":"35","author":"van Asbeck","year":"2009","journal-title":"Crit Rev Microbiol"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","article-title":"Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.","volume":"31","author":"Steinbach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/03007995.2017.1354824","article-title":"Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients.","volume":"33","author":"Harrington","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.01763-15","article-title":"Posttreatment antifungal resistance among colonizing Candida isolates in candidemia patients: results from a systematic multicenter study.","volume":"60","author":"Jensen","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201905000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:24:35Z","timestamp":1694557475000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201905000-00004"}},"subtitle":["A Nationwide Cohort"],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002207","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}